FOXK2 is highly expressed in chronic lymphocytic leukemia (CLL), metastatic breast cancer (MBC), and osteosarcoma clusters and corresponds to poor outcomes in melanoma and non‐small cell lung cancer (NSCLC) cohorts. The gene discussed is FOXK2; the disease is non-small cell lung carcinoma.